Delivery Order SPE2DB22D1202-SPE2DB24FUVR0
Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,485,132 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a completion date of January 31, 2024 and a potential value of $3,734.62. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,205,110 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The delivery order, valued at $26,135.63, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA that serves as the primary contract vehicle for the company to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,655.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,849 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,566,108,780 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a ceiling value of $19,356.90 and a period of performance through October 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a ceiling value of $24,788.61 and a period of performance through April 3, 2024. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $5,542.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4564155597 DUPIXENT 300 MG/2 ML PEN 2ML, with an ultimate completion date of April 4, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,059.09 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563942820 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,084,950 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The $12,696.73 delivery order has a performance period through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds a $999,999,999.00 indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract, valued at $6,609.40, has an ultimate completion date of April 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, valued up to $999,999,999.00 with a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a ceiling value of $23,615.59 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...